There’s been a somewhat interesting development in LabMD’s lawsuit against the FTC in the Georgia federal courts. If I understand that case, LabMD has tried twice – and failed twice – to get the court to consider their complaint, with the courts dismissing their complaints because they were not ripe for review until the administrative…
Search Results for: labmd
Meanwhile, back at FTC v. LabMD
For those of you trying to keep up with developments in the case, here’s the latest one: In response to a motion by the FTC to compel LabMD to file for immunity for Rick Wallace (a former Tiversa employee) under Rule 3.39, Chief Administrative Law Judge Chappell granted in part, and denied in part. LabMD had previously indicated…
LabMD Wants FTC Sanctioned For ‘Secretive Relationship’
Law360 reports: LabMD Inc. asked an administrative law judge on Thursday to sanction the Federal Trade Commission for allegedly having a “secretive relationship” with the source of a key piece of evidence in its ongoing data breach case against the company.LabMD claims the FTC failed to authenticate a key piece of evidence received from a…
With FTC v. LabMD stalled, FTC tries to move the hearing forward
For those following FTC. v. LabMD, here’s a small update. The FTC’s administrative hearing against LabMD came to a screeching halt at the end of May when the House Oversight Committee indicated that it was investigating whether the FTC had based its case against LabMD on erroneous or inaccurate information provided by Tiversa. In the middle…
House Oversight asks Inspector General of the FTC to investigate FTC’s actions in LabMD case
CORRECTION: In the original post, below, the CEO of Tiversa informed PHIprivacy.net that they never turned over the full 1718 File until October 2013, when it was subpoenaed by the FTC. The FTC’s own documents indicate that they obtained the 1718 File from the Privacy Institute in response to the CID, which means that they…
House Oversight notifies FTC of investigation into Tiversa and "less than accurate" information it provided in LabMD case (Update 1)
In a bit of a bombshell, the House Committee on Oversight and Government Reform sent Edith Ramirez, Chairwoman of the FTC, a letter yesterday that provided some details of its investigation of Tiversa and the “less than accurate” and “incomplete” information its CEO, Robert Boback, provided in his testimony to the FTC in its case against LabMD….